Calmare Therapeutics (CTTC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-1979 | |
| Sales | 978 |
| Cost of Goods | 582 |
| Gross Profit | 396 |
| Operating Expenses | 1,660 |
| Operating Income | -682 |
| Other Income | 97 |
| Pre-tax Income | -585 |
| Income Tax | -282 |
| Net Income Continuous | -303 |
| Net Income Discontinuous | 690 |
| Net Income | $387 |
| EBITDA(a) | $-682 |